Cerebral Autoregulation in Patients With Epilepsy
CAPE
1 other identifier
observational
200
1 country
1
Brief Summary
The purpose of this study is to determine whether patients with epilepsy exhibiting impaired dCA, which may contribute to subsequent stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 13, 2016
CompletedFirst Posted
Study publicly available on registry
May 18, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedAugust 25, 2021
March 1, 2017
1.1 years
May 13, 2016
August 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
phase difference(PD) in degree
A dynamic cerebral auto-regulation parameter derived from transfer function analysis.Continuous cerebral blood flow velocities of bilateral middle cerebral artery will be assessed noninvasively using transcranial Doppler. Spontaneous arterial blood pressure will be simultaneously recorded using a servo-controlled plethysmograph on the left or right middle finger with an appropriate finger cuff size. Transfer function analysis will be used to derive the autoregulatory parameters.
1 year
Secondary Outcomes (3)
the rate of recovery of cerebral blood flow velocity
1 year
gain in cm/s/mmHg
1 year
the consequence of electroencephalograph(EEG)
1 year
Study Arms (2)
patients with epilepsy
normal individuals without epilepsy
Eligibility Criteria
Consecutive patients with a diagnosis of epilepsy were recruited from the Department of Neurology, First Hospital of Jilin University, China. Patient was diagnosed with epilepsy by two neurologists according to the consequence of EEG.
You may qualify if:
- patients with epilepsy, as diagnosed by EEG
You may not qualify if:
- patients with status epilepticus
- intracranial and/or extracranial major vascular stenosis/occlusion diagnosed by a transcranial Doppler (EMS-9PB, Delica, China) and carotid ultrasound (IU22, Phillips, Andover, MA)
- a prior symptomatic cerebral vascular disease
- a history of hypertension, cardiovascular disease, diabetes, hyperlipemia, current arrhythmia, hyperthyroidism, anemia and unstable blood pressure, which may undermine hemodynamic stability, or inability to cooperate sufficiently to complete the cerebral auto regulation examination
- insufficient bilateral temporal bone windows for insonation of the middle cerebral artery
- intolerance to cerebral autoregulation measurements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yi Yanglead
Study Sites (1)
First Hospital of Jilin University
Changchun, Jilin, 130000, China
Related Publications (1)
Lv S, Guo ZN, Jin H, Sun X, Jia M, Ma H, Lv Y, Qiu Q, Liu J, Yang Y. Compromised Dynamic Cerebral Autoregulation in Patients with Epilepsy. Biomed Res Int. 2018 Feb 7;2018:6958476. doi: 10.1155/2018/6958476. eCollection 2018.
PMID: 29568762DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yi Yang, MD,PhD
Neuroscience Center, Department of Neurology, The First Hospital of Jilin University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associated Dean of First Hospital of Jilin University
Study Record Dates
First Submitted
May 13, 2016
First Posted
May 18, 2016
Study Start
April 1, 2016
Primary Completion
May 1, 2017
Study Completion
May 1, 2017
Last Updated
August 25, 2021
Record last verified: 2017-03